Skip to main content
THERACRYF PLC logo

THERACRYF PLC — Investor Relations & Filings

Ticker · TCF ISIN · GB00BSVYN304 LEI · 213800NO3E6TSTQO8K20 IL Professional, scientific and technical activities
Filings indexed 361 across all filing types
Latest filing 2020-06-23 Major Shareholding Noti…
Country GB United Kingdom
Listing IL TCF

About THERACRYF PLC

https://theracryf.com/

TheraCryf PLC is a clinical-stage therapeutics company focused on developing a new generation of innovative medicines for behavioural brain disorders and oncology. The company's research and development efforts are centered on sulforaphane-based compounds. Its primary therapeutic focus is on conditions such as opioid and alcohol abuse, binge eating disorder, anxiety, and fatigue. TheraCryf's business strategy is to generate compelling clinical data for its drug candidates with the goal of partnering its programs with larger pharmaceutical companies for late-stage development and commercialization.

Recent filings

Filing Released Lang Actions
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a standard TR-1 form, which is the regulatory notification used in the UK for disclosing major interests in shares. The text explicitly identifies itself as a 'NOTIFICATION OF MAJOR INTEREST IN SHARES' and details the acquisition or disposal of voting rights by a shareholder (Enterprise Ventures Limited) in Evgen Pharma plc. This falls directly under the definition of a Major Shareholding Notification.
2020-06-23 English
Notice of AGM
AGM Information Classification · 98% confidence The document is an announcement from Evgen Pharma PLC regarding the scheduling and logistics of their upcoming Annual General Meeting (AGM). It specifies the date, time, and the fact that it will be held via conference call due to social distancing. It also mentions that the notice and proxy form will be posted to shareholders. Since this is a short announcement regarding the meeting logistics rather than the actual AGM presentation materials or the proxy statement itself, it falls under the category of a regulatory announcement regarding a corporate event.
2020-06-19 English
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a standard 'TR-1: Notification of Major Interest in Shares' form, which is used to report changes in significant share ownership levels (crossing thresholds). This is a classic regulatory disclosure required by the Financial Conduct Authority (FCA) in the UK, specifically categorized as a Major Shareholding Notification.
2020-06-17 English
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a standard TR-1 form, which is the regulatory notification used in the UK for disclosing major interests in shares. The text explicitly identifies itself as a 'NOTIFICATION OF MAJOR INTEREST IN SHARES' and details the change in voting rights held by Enterprise Ventures Limited in Evgen Pharma plc. This falls directly under the definition of a Major Shareholding Notification.
2020-06-17 English
SFX-01 to be evaluated in COVID-19 trial
Regulatory Filings Classification · 98% confidence The document is an RNS (Regulatory News Service) announcement from Evgen Pharma PLC regarding the participation of their product SFX-01 in a COVID-19 clinical trial. It is a corporate news release detailing operational developments rather than a financial report, audit, or proxy statement. Since it does not fit into specific categories like M&A or management changes, it falls under the general regulatory announcement category.
2020-06-17 English
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a 'TR-1: Standard form for notification of major holdings', which is the regulatory standard in the UK for disclosing changes in significant share ownership. This document explicitly details the threshold crossing of voting rights by a shareholder (David and Monique Newlands) in Evgen Pharma PLC. This fits the definition of a Major Shareholding Notification (MRQ).
2020-06-15 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.